LYC Healthcare Berhad (0075) Fair Value & Analysis
Technology · MY · Market cap 7.4M MYR
Fair value as of: Jun 26, 2026
Analysis
LYC Healthcare Berhad (0075) currently trades at 0.0150 MYR, while our model-based Fair Value estimate is 0.0145 MYR — implying the stock looks roughly 3.3% overvalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
LYC Healthcare Berhad provides health care services primarily in Malaysia and Singapore. The company operates through three segments: Healthcare Services, Computing and Electronic Services, and Other segments. It engages in the provision of mother and childcare related services, such as postnatal and postpartum care, post-delivery confinement care, and aesthetics; healthcare related services; cosmetics related and medical aesthetic treatment services; dental treatment and consultancy; child daycare; and medical and surgical advisory services, as well as deals in raw and finished, consumable and non-consumable food ingredients. The company also offers research and development; e-manufacturing solutions and IT outsourcing services; and computer and its related products. In addition, it provides business management consultant services; infrastructure for hosting and data processing services; general medical and prostate cancer treatment services; personal care, wellness, and promotion/…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is LYC Healthcare Berhad (0075) undervalued?
What is the fair value of 0075?
What is the quality score of 0075?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.